PDIA6 and eosinophilia-myalgia syndrome: Notably, the upregulation of genes such as HSPA5, HSP90B1, PDIA6, and HERPUD1 correlated closely with the clinical features of EMs, suggesting their potential as biomarkers for EMs diagnosis and prognosis.